Dr Susan Wyllie
Biological Chemistry and Drug Discovery, School of Life Sciences
Dr Susan Wyllie has more than 15 years of experience studying kinetoplastid biology. Specifically, her research has focused on determining the mechanisms of action and mechanisms of resistance of drugs targeting kinetoplastid parasites. Her contributions to the research of the Wellcome Centre for Anti-Infectives Research will include:
- Using complementary methodologies in the fields of genomics, chemical proteomics and cell biology to determine the modes of action and specific molecular targets of phenotypically-active compounds
- Developing new genetic and cell biology tools for the study of drug mechanism of action
- Functional characterisation of novel targets
- Developing novel cell-based assays to exploit high value drug targets
I am available for media commentary on my research.
Contact Corporate Communications for media enquiries.
Areas of expertise
- Infectious diseases
|National Sciences Prizes awarded since 1990 / C.A. Wright Memorial Medal
|Innovator of the Year
Breakthrough research at the University of Dundee may lead to treatments that make two deadly parasitic infections a thing of the past.
A collaboration between the research laboratories of Dr Mattie Pawlowic and Dr Susan Wyllie in the Wellcome Centre for Anti-Infectives Research at School of Life Sciences has generated a new tool that can be used for studying Cryptosporidium.
Dr Susan Wyllie has been awarded the prestigious C.A. Wright Memorial Medal from the British Society for Parasitology in recognition of her outstanding contribution to the discipline.